TC BioPharm Ltd
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Biotechnology
- Gene Therapy, Cell Therapy
- Drug Discovery Technologies
- ADMET
Other Names/Subsidiaries
- TC BioPharm, Ltd.
Latest on TC BioPharm Ltd
The state of the financial markets for biopharmaceutical companies in 2024 is about as unpredictable as the weather in San Francisco during the annual J.P. Morgan Healthcare Conference. The forecast f
The University of Texas MD Anderson Cancer Center and US/UK biotech Replay announced on 14 February that they are launching a new company, Syena, to advance research conducted at the cancer center o
The biopharmaceutical industry is nearing the one-month mark without an initial public offering in the US as biotechnology stock values continue to plummet, mirroring the slowdown across industries as
Twelve biopharmaceutical companies announced venture capital financings totaling $672m between 7 and 11 February, which was another relatively quiet week for public company offerings. With biotechnolo